MRK registry changes
Status changes, moved primary completion and completion dates, and results first posted on ClinicalTrials.gov, for trials linked to listed companies. Newest detection first.
Newest change detected Nov 19, 2026, 8:47 AM ET
| Detected | Trial | Change | Now | Before | Record updated |
|---|---|---|---|---|---|
| Nov 19, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 19, 2026, 8:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 18, 2026, 9:47 AM ET | Status | Terminated | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 17, 2026, 9:52 AM ET | Status | Completed | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Status | Active, not recruiting | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Status | Recruiting | Locked | Locked | |
| Nov 16, 2026, 8:47 AM ET | Status | Completed | Locked | Locked | |
| Nov 13, 2026, 9:47 AM ET | Status | Completed | Locked | Locked |
- Detected Nov 19, 2026, 8:47 AM ETStatusNCT04652076GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or PembrolizumabMRK
- Now
- Completed
- Before
- Locked
- Detected Nov 19, 2026, 8:47 AM ETStatus
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 18, 2026, 9:47 AM ETStatusNCT04428151Lenvatinib (E7080/MK-7902) in Combination With Pembrolizumab (MK-3475) vs. Standard Chemotherapy and Lenvatinib Monotherapy in...MRK
- Now
- Terminated
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatusNCT07862595A Clinical Trial of MK-6916 in Participants With Pain After Bunion Removal Surgery (MK-6916-007)MRK
- Now
- Recruiting
- Before
- Locked
- Detected Nov 17, 2026, 9:52 AM ETStatus
- Now
- Completed
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETStatusNCT04652076GYNecological Cancers Treated With NETrin mAbs in Combination With Chemotherapy and /or PembrolizumabMRK
- Now
- Active, not recruiting
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETStatusNCT07015853ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and RadiationMRKINCY
- Now
- Recruiting
- Before
- Locked
- Detected Nov 16, 2026, 8:47 AM ETStatusNCT04713514OSE2101 Alone or in Combination With Pembrolizumab vs BSC in Patient With Platinum-sensitive Recurrent OCMRK
- Now
- Completed
- Before
- Locked
- Detected Nov 13, 2026, 9:47 AM ETStatusNCT04895722Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite...MRK
- Now
- Completed
- Before
- Locked
The previous value and the sponsor's record update date are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerTracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.
What is on this list
Changes Signal8 recorded between two refreshes of a trial's ClinicalTrials.gov record: status, primary completion and completion dates, and results first posted. A change is shown when it was detected, which can be days after the sponsor updated the record. Nothing here describes what a trial showed.
New registrations, enrollment, eligibility and outcome-measure edits are not recorded. A status change is the registry's own word for where the trial stands, and "results posted" means results were posted to the registry, never what they show.
Free readers see the first 25 changes of any filter with the new value. The previous value, the sponsor's record update date and later pages are part of the plan. See the methodology.